The number of prescription drug shortages in the U.S. has decreased overall but the duration of existing shortages has significantly increased, now averaging over five years. Concurrently, European countries are facing divergent approaches to drug pricing, influenced by U.S. policies. This situation highlights ongoing challenges in pharmaceutical supply chains and pricing negotiations, impacting the availability and cost of critical medicines for patients and healthcare providers.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
13
Ali NematiWritten by Ali
